PARIS–(BUSINESS WIRE)– #VC–Sofinnova Partners announced that its portfolio company, Amolyt Pharma, has entered into a definitive agreement with AstraZeneca for its acquisition.
Business Wire Merger/Acquisition News
Enjoying Merger Arbitrage Limited?
Sign up then! It's quick and FREE
Have time to share an article? It's very much appreciated!!